Johnson & Johnson jets to Washington for FDLI conference close

Johnson & Johnson flew from Trenton Mercer Airport in New Jersey to Ronald Reagan Washington National Airport on May 7, 2026, a brisk 39-minute hop in its Gulfstream G650ER, tail number N400J. The flight departed at 6:07 p.m. local time, covering just over 200 miles at a modest 12,100 feet, the kind of quick jaunt that underscores the company's routine shuttles between its New Jersey headquarters and the nation's capital.

The timing aligns neatly with the wrap-up of the 2026 FDLI Annual Conference, held May 6-7 at the nearby Ronald Reagan Building and International Trade Center, as detailed on the Food and Drug Law Institute's event page. This gathering draws regulators, industry leaders, and legal experts to dissect the latest in food and drug policy—essential fare for a pharma titan like Johnson & Johnson, whose portfolio spans everything from vaccines to medical devices amid ongoing FDA scrutiny.

This DC dash follows a flurry of transatlantic legs earlier in the week, tracing from Paris and Madrid across the Atlantic to New Jersey landings on May 6, per flight tracking data. With recurring trips to area airports like Dulles, such patterns hint at executives circling back from European boardrooms or partnerships to navigate Washington's regulatory waters, where billions in approvals hang in the balance.